Nutrien Ltd. (NYSE:NTR) Given Consensus Recommendation of “Moderate Buy” by Analysts

Nutrien Ltd. (NYSE:NTR) has been assigned a consensus recommendation of “Moderate Buy” from the nineteen analysts that are presently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, seven have given a hold rating and eleven have assigned a buy rating to the company. The average 12 month price objective among brokers that have covered the stock in the last year is $82.75.

NTR has been the subject of several recent analyst reports. Raymond James Financial raised Nutrien from a “market perform” rating to an “outperform” rating and raised their target price for the stock from $74.00 to $90.00 in a research report on Tuesday, May 5th. BMO Capital Markets lifted their price objective on Nutrien from $85.00 to $90.00 and gave the company an “outperform” rating in a research report on Wednesday, March 18th. TD Securities reissued a “buy” rating on shares of Nutrien in a research report on Wednesday, May 6th. Oppenheimer lifted their price objective on Nutrien from $80.00 to $82.00 and gave the company an “outperform” rating in a research report on Tuesday, May 12th. Finally, Weiss Ratings raised Nutrien from a “hold (c)” rating to a “hold (c+)” rating in a research report on Monday, June 1st.

Nutrien Stock Performance

Shares of Nutrien stock opened at $67.17 on Friday. The stock has a market cap of $32.24 billion, a PE ratio of 13.68, a price-to-earnings-growth ratio of 0.62 and a beta of 0.60. The business has a fifty day simple moving average of $72.22 and a 200-day simple moving average of $68.81. The company has a quick ratio of 0.59, a current ratio of 1.24 and a debt-to-equity ratio of 0.35. Nutrien has a 12 month low of $53.03 and a 12 month high of $85.36.

Nutrien (NYSE:NTR) last issued its earnings results on Wednesday, May 6th. The company reported $0.51 EPS for the quarter, topping the consensus estimate of $0.48 by $0.03. The business had revenue of $6.05 billion during the quarter, compared to analysts’ expectations of $5.30 billion. Nutrien had a return on equity of 8.84% and a net margin of 8.58%.Nutrien’s revenue was up 18.5% compared to the same quarter last year. During the same quarter last year, the firm posted $0.11 earnings per share. On average, sell-side analysts anticipate that Nutrien will post 5.45 EPS for the current fiscal year.

Nutrien Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 17th. Investors of record on Tuesday, June 30th will be given a dividend of $0.55 per share. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $2.20 dividend on an annualized basis and a yield of 3.3%. Nutrien’s dividend payout ratio (DPR) is presently 44.81%.

Institutional Trading of Nutrien

A number of institutional investors have recently bought and sold shares of the company. Guggenheim Capital LLC boosted its position in Nutrien by 2.2% during the fourth quarter. Guggenheim Capital LLC now owns 6,628 shares of the company’s stock valued at $409,000 after purchasing an additional 145 shares during the last quarter. Minot DeBlois Advisors LLC boosted its position in Nutrien by 1.8% during the fourth quarter. Minot DeBlois Advisors LLC now owns 9,032 shares of the company’s stock valued at $557,000 after purchasing an additional 164 shares during the last quarter. Banque Cantonale Vaudoise boosted its position in Nutrien by 15.9% during the first quarter. Banque Cantonale Vaudoise now owns 1,198 shares of the company’s stock valued at $90,000 after purchasing an additional 164 shares during the last quarter. Gould Asset Management LLC CA boosted its position in Nutrien by 4.4% during the first quarter. Gould Asset Management LLC CA now owns 3,933 shares of the company’s stock valued at $297,000 after purchasing an additional 165 shares during the last quarter. Finally, Smith Moore & CO. boosted its position in Nutrien by 2.2% during the third quarter. Smith Moore & CO. now owns 7,642 shares of the company’s stock valued at $449,000 after purchasing an additional 168 shares during the last quarter. Institutional investors and hedge funds own 63.10% of the company’s stock.

About Nutrien

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.